Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03570554 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale
A Phase 2 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT03570554 is a Phase 2 study that has completed, run by Bayer. The registered enrollment target is 41 participants.
The verdict
NCT03570554, a Phase 2 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
Osteoarthritis is a common, chronic, progressive, skeletal, degenerative disorder that frequently affects several joints such as knee, hip, spine and hands.This placebo-controlled clinical trial assessed the effects of naproxen sodium, acetaminophen and celecoxib on stiffness in subjects with osteoarthritis.
Interventions
- DRUG Placebo
- DRUG Celecoxib
- DRUG Naproxen Sodium (Aleve, BAY117031)
- DRUG Acetaminophen ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-06-29 |
| Est. Completion | 2019-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03570554
The ClinicalTrials.gov registry entry for NCT03570554 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03570554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03570554 about?
NCT03570554 is a clinical study titled "A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale". Osteoarthritis is a common, chronic, progressive, skeletal, degenerative disorder that frequently affects several joints such as knee, hip, spine and hands.This placebo-controlled clinical trial assessed the effects of naproxen sodium, acetaminophen and celecoxib on stiffness in subjects with osteoa...
What is the current status of trial NCT03570554?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2018-06-29. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03570554?
The interventions under investigation include: Placebo (DRUG), Celecoxib (DRUG), Naproxen Sodium (Aleve, BAY117031) (DRUG), Acetaminophen ER (DRUG).
Who is sponsoring clinical trial NCT03570554?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.